|
1
|
Pihlstrom BL, Michalowicz BS and Johnson
NW: Periodontal diseases. Lancet. 366:1809–1820. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bartold PM, Cantley MD and Haynes DR:
Mechanisms and control of pathologic bone loss in periodontitis.
Periodontology. 53:55–69. 2000. View Article : Google Scholar
|
|
3
|
Arron JR and Choi Y: Bone versus immune
system. Nature. 408:535–536. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheng WC, Hughes FJ and Taams LS: The
presence, function and regulation of IL-17 and Th17 cells in
periodontitis. J Clin Periodontol. 41:541–549. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen XT, Tan JY, Lei LH and Chen LL:
Cytokine levels in plasma and gingival crevicular fluid in chronic
periodontitis. Am J Dent. 28:9–12. 2015.PubMed/NCBI
|
|
6
|
Chen XT, Chen LL, Tan JY, Shi DH, Ke T and
Lei LH: Th17 and Th1 lymphocytes are correlated with chronic
periodontitis. Immunol Invest. 45:243–254. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
da Costa TA, Silva MJ, Alves PM, Chica JE,
Barcelos EZ, Giani MA, Garlet GP, da Silva JS, Júnior V Rodrigues,
Rodrigues DB and Cardoso CR: Inflammation biomarkers of advanced
disease in nongingival tissues of chronic periodontitis patients.
Mediators Inflamm. 2015:9837822015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu JJ, Ruddy MJ, Wong GC, Sfintescu C,
Baker PJ, Smith JB, Evans RT and Gaffen SL: An essential role for
IL-17 in preventing pathogen-initiated bone destruction:
Recruitment of neutrophils to inflamed bone requires IL-17
receptor-dependent signals. Blood. 109:3794–3802. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Settem RP, Honma K, Nakajima T, Phansopa
C, Roy S, Stafford GP and Sharma A: A bacterial glycan core linked
to surface (S)-layer proteins modulates host immunity through Th17
suppression. Mucosal Immunol. 6:415–426. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Van Bezooijen RL, Farih-Sips HC,
Papapoulos SE and Löwik CW: Interleukin-17: A new bone acting
cytokine in vitro. J Bone Miner Res. 14:1513–1521. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen LL, Huang M, Tan JY, Chen XT, Lei LH,
Wu YM and Zhang DY: PI3K/AKT pathway involvement in the osteogenic
effects of osteoclast culture supernatants on preosteoblast cells.
Tissue Eng Part A. 19:2226–2232. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mukherjee A, Wilson EM and Rotwein P:
Selective signaling by Akt2 promotes bone morphogenetic protein
2-mediated osteoblast differentiation. Mol Cell Biol. 30:1018–1027.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cantley LC: The phosphoinositide 3-kinase
pathway. Science. 296:1655–1657. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Melton AC, Melrose J, Alajoki L, Privat S,
Cho H, Brown N, Plavec AM, Nguyen D, Johnston ED, Yang J, et al:
Regulation of IL-17A production is distinct from IL-17F in a
primary human cell co-culture model of T cell-mediated B cell
activation. PLoS One. 8:e589662013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Webster KE, Kim HO, Kyparissoudis K,
Corpuz TM, Pinget GV, Uldrich AP, Brink R, Belz GT, Cho JH, Godfrey
DI and Sprent J: IL-17-producing NKT cells depend exclusively on
IL-7 for homeostasis and survival. Mucosal Immunol. 7:1058–1067.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park YD, Kim YS, Jung YM, Lee SI, Lee YM,
Bang JB and Kim EC: Porphyromonas gingivalis lipopolysaccharide
regulates interleukin (IL)-17 and IL-23 expression via SIRT1
modulation in human periodontal ligament cells. Cytokine.
60:284–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sudo H, Kodama HA, Amagai Y, Yamamoto S
and Kasai S: In vitro differentiation and calcification in a new
clonal osteogenic cell line derived from newborn mouse calvaria. J
Cell Biol. 96:191–198. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang D, Christensen K, Chawla K, Xiao G,
Krebsbach PH and Franceschi RT: Isolation and characterization of
MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo
differentiation/mineralization potential. J Bone Miner Res.
14:893–903. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jeon EJ, Lee KY, Choi NS, Lee MH, Kim HN,
Jin YH, Ryoo HM, Choi JY, Yoshida M, Nishino N, et al: Bone
morphogenetic protein-2 stimulates Runx2 acetylation. J Biol Chem.
281:16502–16511. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lester SR, Bain JL, Johnson RB and Serio
FG: Gingival concentrations of interleukin-23 and −17 at healthy
sites and at sites of clinical attachment loss. J Periodontol.
78:1545–1550. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ohyama H, Kato-Kogoe N, Kuhara A,
Nishimura F, Nakasho K, Yamanegi K, Yamada N, Hata M, Yamane J and
Terada N: The involvement of IL-23 and the Th17 pathway in
periodontitis. J Dent Res. 88:633–638. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Martin KA, Merenick BL, Ding M, Fetalvero
KM, Rzucidlo EM, Kozul CD, Brown DJ, Chiu HY, Shyu M, Drapeau BL,
et al: Rapamycin promotes vascular smooth muscle cell
differentiation through insulin receptor
substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling.
J Biol Chem. 282:36112–36120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stein GS and Lian JB: Molecular mechanisms
mediating proliferation/differentiation interrelationships during
progressive development of the osteoblast phenotype. Endocr Rev.
14:424–442. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vinals F, Lopez-Rovira T, Rosa JL and
Ventura F: Inhibition of PI3K/p70 S6K and p38 MAPK cascades
increases osteoblastic differentiation induced by BMP-2. FEBS Lett.
510:99–104. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Martin SK, Fitter S, Bong LF, Drew JJ,
Gronthos S, Shepherd PR and Zannettino AC: NVP-BEZ235, a dual pan
class I PI3 Kinase and mTOR inhibitor, promotes osteogenic
differentiation in human mesenchymal stromal cells. J Bone Miner
Res. 25:2126–2137. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gu YX, Du J, Si MS, Mo JJ, Qiao SC and Lai
HC: The roles of PI3K/Akt signaling pathway in regulating MC3T3-E1
preosteoblast proliferation and differentiation on SLA and SLActive
titanium surfaces. J Biomed Mater Res A. 101:748–754. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dangi S, Cha H and Shapiro P: Requirement
for phosphatidylinositol-3 kinase activity during progression
through S-phase and entry into mitosis. Cell Signal. 15:667–675.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Valente AJ, Yoshida T, Gardner JD, Somanna
N, Delafontaine P and Chandrasekar B: Interleukin-17A stimulates
cardiac fibroblast proliferation and migration via negative
regulation of the dual-specificity phosphatase MKP-1/DUSP-1. Cell
Signal. 24:560–568. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nograles KE, Zaba LC, Guttman-Yassky E,
Fuentes-Duculan J, Suárez-Fariñas M, Cardinale I, Khatcherian A,
Gonzalez J, Pierson KC, White TR, et al: Th17 cytokines interleukin
(IL)-17 and IL-22 modulate distinct inflammatory and
keratinocyte-response pathways. Br J Dermatol. 159:1092–1102.
2008.PubMed/NCBI
|
|
32
|
Komori T: Runx2, a multifunctional
transcription factor in skeletal development. J Cell Biochem.
87:1–8. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mundy GR and Elefteriou F: Boning up on
ephrin signaling. Cell. 126:441–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dong C: Diversification of T-helper-cell
lineages: Finding the family root of IL-17-producing cells. Nat Rev
Immunol. 6:329–333. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nam D, Mau E, Wang Y, Wright D, Silkstone
D, Whetstone H, Whyne C and Alman B: T-lymphocytes enable
osteoblast maturation via IL-17F during the early phase of fracture
repair. PLoS One. 7:e400442012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Luan J, Cui Y, Zhang Y, Zhou X, Zhang G
and Han J: Effect of CXCR4 inhibitor AMD3100 on alkaline
phosphatase activity and mineralization in osteoblastic MC3T3-E1
cells. Biosci Trends. 6:63–69. 2012.PubMed/NCBI
|
|
37
|
Fujita T, Azuma Y, Fukuyama R, Hattori Y,
Yoshida C, Koida M, Ogita K and Komori T: Runx2 induces osteoblast
and chondrocyte differentiation and enhances their migration by
coupling with PI3K-Akt signaling. J Cell Biol. 166:85–95. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gaffen SL: Structure and signalling in the
IL-17 receptor family. Nat Rev Immunol. 9:556–567. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ghosh-Choudhury N, Abboud SL, Nishimura R,
Celeste A, Mahimainathan L and Choudhury GG: Requirement of
BMP-2-induced phosphatidylinositol 3-kinase and Akt
serine/threonine kinase in osteoblast differentiation and
Smad-dependent BMP-2 gene transcription. J Biol Chem.
277:33361–33368. 2002. View Article : Google Scholar : PubMed/NCBI
|
